1. These Regulations may be cited as the Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 and come into force immediately before IP completion day.
Commencement Information
I1Reg. 1 in force at 31.12.2020 immediately before IP completion day, see reg. 1
2. In the Good Laboratory Practice Regulations 1999 M1—
(a)omit regulation 5(4)(b) (and the “or” at the end of sub-paragraph (a)), and
(b)in regulation 6(4), omit “unless, in order” to the end.
Commencement Information
I2Reg. 2 in force at 31.12.2020 immediately before IP completion day, see reg. 1
Marginal Citations
3. The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019 M2 are amended in accordance with Schedule 1.
Commencement Information
I3Reg. 3 in force at 31.12.2020 immediately before IP completion day, see reg. 1
Marginal Citations
4. The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 M3 are amended in accordance with Schedule 2.
Commencement Information
I4Reg. 4 in force at 31.12.2020 immediately before IP completion day, see reg. 1
Marginal Citations
5. The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019 M4 are amended in accordance with Schedule 3.
Commencement Information
I5Reg. 5 in force at 31.12.2020 immediately before IP completion day, see reg. 1
Marginal Citations
Signed by authority of the Secretary of State for Health and Social Care
Edward Argar
Minister of State,
Department of Health and Social Care
We consent
Maggie Throup
Rebecca Harris
Two of the Lords Commissioners of Her Majesty's Treasury